Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations.
Carolin OttoTatjana SchwarzLara M JeworowskiMarie L SchmidtFelix WalperFlorence PachePatrick SchindlerMoritz NiederschweibererAndi KrumbholzRuben RoseChristian DrostenKlemens RuprechtVictor Max CormanPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Additional vaccinations qualitatively improve SARS-CoV-2 antibody responses.